Letrozole and Urine output decreased - a phase IV clinical study of FDA data

Summary:

Urine output decreased is found among people who take Letrozole, especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months.

The phase IV clinical study analyzes which people take Letrozole and have Urine output decreased. It is created by eHealthMe based on reports of 31,575 people who have side effects when taking Letrozole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On May, 22, 2022

31,575 people reported to have side effects when taking Letrozole.
Among them, 27 people (0.09%) have Urine output decreased.

What is Letrozole?

Letrozole has active ingredients of letrozole. It is often used in breast cancer. eHealthMe is studying from 32,043 Letrozole users for its effectiveness, alternative drugs and more.

What is Urine output decreased?

Urine output decreased is found to be associated with 1,670 drugs and 1,094 conditions by eHealthMe.

Number of Letrozole and Urine output decreased reports submitted per year:

Could Letrozole cause Urine output decreased?

Time on Letrozole when people have Urine output decreased *:

Gender of people who have Urine output decreased when taking Letrozole *:

female: 100 %
male: 0.0 %

Age of people who have Urine output decreased when taking Letrozole *:

Common drugs people take besides Letrozole *:

Common side effects people have besides Urine output decreased *:

Fatigue (feeling of tiredness): 22 people, 81.48%
Abdominal Distension: 21 people, 77.78%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 21 people, 77.78%
Nausea (feeling of having an urge to vomit): 21 people, 77.78%
Sepsis (a severe blood infection that can lead to organ failure and death): 20 people, 74.07%
Confusional State: 20 people, 74.07%
Dehydration (dryness resulting from the removal of water): 20 people, 74.07%
Hypotension (abnormally low blood pressure): 20 people, 74.07%
Weakness: 20 people, 74.07%
Breathing Difficulty: 19 people, 70.37%

Common conditions people have *:

Type 2 Diabetes: 2 people, 7.41%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 7.41%
Menopause (end of monthly cycles in women): 2 people, 7.41%
Lacrimation Increased: 2 people, 7.41%
High Blood Pressure: 2 people, 7.41%
Depression: 2 people, 7.41%
Ovulation Induction: 1 person, 3.70%
Neoplasm Malignant (cancer tumour): 1 person, 3.70%
Metastases To Bone (cancer spreads to bone): 1 person, 3.70%
Constipation: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Letrozole and have Urine output decreased?

Check whether Urine output decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of Letrozole:

Letrozole (32,043 reports)

Urine output decreased treatments and more:

Urine output decreased (9,455 reports)

COVID vaccines that are related to Urine output decreased:

How severe was Urine output decreased and when was it recovered:

Urine output decreased in Letrozole

Expand to all the drugs that have ingredients of letrozole:

Urine output decreased and drugs with ingredients of letrozole

Common drugs associated with Urine output decreased:

How the study uses the data?

The study uses data from the FDA. It is based on letrozole (the active ingredients of Letrozole) and Letrozole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.